DWK Life Sciences: De Risking Sterile Processing with DURAN™ PURE RTU - The Ready to Use Advantage

Rising regulatory requirements, particularly under Annex 1, are transforming how pharmaceutical organisations approach container preparation. Greater emphasis on contamination control and process consistency is driving the need for more standardised, tightly controlled workflows. As a result, companies are re-evaluating in-house preparation steps to ensure compliance while maintaining efficiency.

Ready-to-use (RTU) solutions help reduce internal workload by outsourcing washing, depyrogenation, and sterilisation to qualified partners. This not only frees up valuable resources but also mitigates capacity constraints and strengthens regulatory confidence through validated processes. With options such as RTP, RTS, and RTU, organisations can select the level of preparation that best fits their operational and compliance needs.

By combining DURAN™ PURE bioprocessing containers with tailored RTU services, pharma and biotech companies can reduce contamination risk, eliminate process bottlenecks, and improve overall workflow efficiency. Real-world applications demonstrate measurable gains in productivity and total cost of ownership, making RTU an increasingly attractive strategy for modern sterile manufacturing.

Discover the Product